TY - JOUR
T1 - Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage
AU - Dvoriantchikova, Galina
AU - Degterev, Alexei
AU - Ivanov, Dmitry
N1 - Funding Information:
Supported in part by National Eye Institute / National Institutes of Health (NIH) Grant R01 EY022348 (DI), James and Esther King Biomedical Research Program Bridge Grant 3KB01-50988 (DI), National Institute of General Medical Sciences grants R01GM080356 and R01GM084205 (AD), NIH Center Core Grant P30EY014801 , Research to Prevent Blindness Unrestricted Grant, Department of Defense (DOD-Grant # W81XWH-09-1-0675 and Grant # W81XWH-13-1-0048 ONOVA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Eye Institute or the National Institutes of Health. The authors thank Eleut Hernandez, Andrea Rachelle C. Santos, Dagmara Danek and Gabriel Gaidosh for their expert assistance.
PY - 2014/6
Y1 - 2014/6
N2 - Retinal ischemia-reperfusion (IR) injury remains a common cause of blindness and has a final pathway of retinal ganglion cell (RGC) death by apoptosis and necrosis. RGC apoptosis was intensively studied in IR injury, while RGC necrosis did not receive nearly enough consideration since it was viewed as an accidental and unregulated cellular event. However, there is evidence that necrosis, like apoptosis, can be implemented by a programmed mechanism. In this study, we tested the role of RGC programmed necrosis (necroptosis) in IR-induced retinal injury. We employed the mouse model of retinal IR injury for invivo experiments. The oxygen and glucose deprivation (OGD) model was used as an IR model invitro. Primary RGCs were isolated by an immunopanning technique. Necrostatin 1 (Nec1) was used to inhibit necroptosis in invitro and invivo experiments. The changes in gene expression were assessed by quantitative RT-PCR. The distribution of proteins in the retina and in RGC cultures was evaluated by immunohistochemistry and immunocytochemistry, respectively. Our data suggest that proteins (Ripk1 and Ripk3), which initiate necroptosis, were present in normal and ischemic RGCs. Treatment with Nec1 significantly reduced retinal damage after IR. Increased RGC survival and reduced RGC necrosis following OGD were observed in Nec1-treated cultures. We found significantly reduced expression of genes coding pro-inflammatory markers Il1b, Ccl5, Cxcl10, Nos2 and Cybb in Nec1-treated ischemic retinas. Thus, our findings suggest that RGC necroptosis contributes to retinal damage after IR through direct loss of cells and induction of associated inflammatory responses.
AB - Retinal ischemia-reperfusion (IR) injury remains a common cause of blindness and has a final pathway of retinal ganglion cell (RGC) death by apoptosis and necrosis. RGC apoptosis was intensively studied in IR injury, while RGC necrosis did not receive nearly enough consideration since it was viewed as an accidental and unregulated cellular event. However, there is evidence that necrosis, like apoptosis, can be implemented by a programmed mechanism. In this study, we tested the role of RGC programmed necrosis (necroptosis) in IR-induced retinal injury. We employed the mouse model of retinal IR injury for invivo experiments. The oxygen and glucose deprivation (OGD) model was used as an IR model invitro. Primary RGCs were isolated by an immunopanning technique. Necrostatin 1 (Nec1) was used to inhibit necroptosis in invitro and invivo experiments. The changes in gene expression were assessed by quantitative RT-PCR. The distribution of proteins in the retina and in RGC cultures was evaluated by immunohistochemistry and immunocytochemistry, respectively. Our data suggest that proteins (Ripk1 and Ripk3), which initiate necroptosis, were present in normal and ischemic RGCs. Treatment with Nec1 significantly reduced retinal damage after IR. Increased RGC survival and reduced RGC necrosis following OGD were observed in Nec1-treated cultures. We found significantly reduced expression of genes coding pro-inflammatory markers Il1b, Ccl5, Cxcl10, Nos2 and Cybb in Nec1-treated ischemic retinas. Thus, our findings suggest that RGC necroptosis contributes to retinal damage after IR through direct loss of cells and induction of associated inflammatory responses.
KW - Ischemia-reperfusion
KW - Necroptosis
KW - Necrostatin 1
KW - Retinal damage
KW - Retinal ganglion cells
KW - Ripk1
KW - Ripk3
UR - http://www.scopus.com/inward/record.url?scp=84899833069&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899833069&partnerID=8YFLogxK
U2 - 10.1016/j.exer.2014.04.009
DO - 10.1016/j.exer.2014.04.009
M3 - Article
C2 - 24751757
AN - SCOPUS:84899833069
VL - 123
SP - 1
EP - 7
JO - Experimental Eye Research
JF - Experimental Eye Research
SN - 0014-4835
ER -